First Commercial Batch of Covaxin Released from Bharat Biotech's New Plant


The government had earlier this month given approval to Bharat Biotech’s Ankleshwar-based manufacturing plant to produce anti-COVID-19 vaccine Covaxin.

The authorities had earlier this month given approval to Bharat Biotech’s Ankleshwar-based manufacturing plant to supply anti-COVID-19 vaccine Covaxin.

The authorities had earlier this month given approval to Bharat Biotech’s Ankleshwar-based manufacturing plant to supply anti-COVID-19 vaccine Covaxin.

  • PTI Ankleshwar
  • Last Updated:August 29, 2021, 15:01 IST
  • FOLLOW US ON:

The first business batch of Covaxin was launched on Sunday from the brand new plant of Bharat Biotech at Ankleshwar in Gujarat’s Bharuch district by Union Health Minister Mansukh Mandaviya. ”Vaccination is crucial factor to strengthen the nation’s battle in opposition to coronavirus. Released the primary business batch of #COVAXIN from Bharat Biotech’s plant at Ankleshwar, Gujarat immediately. This will enhance the availability of vaccine within the nation and can assist the vaccine attain each Indian,” Mandaviya tweeted quickly after the occasion.

The authorities had earlier this month given approval to Bharat Biotech’s Ankleshwar-based manufacturing plant to supply anti-COVID-19 vaccine Covaxin. In May, Bharat Biotech introduced that it deliberate to supply an extra 200 million doses of Covaxin at its subsidiary’s Ankleshwar-based facility. The Hyderabad-based agency had famous that it will utilise the manufacturing plant of its wholly-owned unit, Chiron Behring, so as to add one other 200 million doses of Covaxin. India administered 63.09 crore doses of COVID-19 vaccination in a nationwide drive until Sunday morning, as per the information launched by the Union Health Ministry.

Read all of the Latest News, Breaking News and Coronavirus News right here

Leave a Reply

Your email address will not be published. Required fields are marked *